The use of medications for inflammatory bowel disease during pregnancy and nursing

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 11, 2005, Pages 1833-1839

  Sauk, Jenny ^a   Kane, Sunanda ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Crohn's disease; Medications; Pregnancy; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTIDIARRHEAL AGENT; ATROPINE PLUS DIPHENOXYLATE; AZATHIOPRINE; BETAMETHASONE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; FOLIC ACID; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; OLASALAZINE; OPIATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; THALIDOMIDE; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; BLOOD PLACENTA BARRIER; BONE MARROW SUPPRESSION; BREAST FEEDING; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG METABOLISM; DRUG MILK LEVEL; DRUG PENETRATION; DRUG SAFETY; FEMALE; FETUS; HEMOLYTIC ANEMIA; HUMAN; INTERSTITIAL NEPHRITIS; KERNICTERUS; LOW BIRTH WEIGHT; MEGALOBLASTIC ANEMIA; NEPHROTOXICITY; NEURAL TUBE DEFECT; PANCREATITIS; PREGNANCY; PREMATURITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SPERMATOZOON ABNORMALITY; SPONTANEOUS ABORTION; TERATOGENICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; BREAST FEEDING; CLINICAL TRIALS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FETUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; SULFASALAZINE;

EID: 25444521064     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.11.1833     Document Type: Review

References (57)

1. HANAUER SB, PRESENT DH: The state of the art in the management of inflammatory bowel disease. Rev. Gastroenterol. Disord. (2003) 3:81-92.
2. BANKS BM, KORELITZ BI, ZETZEL L: The course of nonspecific ulcerative colitis: review of twenty years' experience and late results. Gastroenterology (1957) 32:983-1012.
3. LINDHAGEN T, BOHE M, VALENTIN L et al.: Fertility and outcome of pregnancy in patients operated on for Crohn's disease. Int. J. Colorectal Dis. (1986) 1:25-27.
4. WILLOUGHBY CP, TRUELOVE SC: Ulcerative colitis and pregnancy. Gut (1980) 21:469-474.
5. MILLER JP: Inflammatory bowel disease in pregnancy: a review. J. R. Soc. Med. (1986) 79:221-225.
6. KHOSLA R, WILLOUGHBY CP, JEWELL DP: Crohn's disease and pregnancy. Gut (1984) 25:52-56.
7. MOGADAM M, KORELITZ BI, BAIOCCO PJ et al.: The course of inflammatory bowel disease during pregnancy and postpartum. Am. J. Gastroenterol. (1981) 75:265-269.
8. DONALDSON RM, JR: Management of medical problems in pregnancy-inflammatory bowel disease. N. Engl. J. Med. (1985) 312:1616-1619.
9. BAIOCCO PJ, KORELITZ BI: The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J. Clin. Gastroenterol. (1984) 6:211-216.
10. KORNFELD D, CNATTINGIUS S, EKBOM A: Pregnancy outcomes in women with inflammatory bowel disease-a population-based cohort study. Am. J. Obstet. Gynecol. (1997) 177:942-946.
11. SCHADE RR, VAN THIEL DH, GAVALER JS: Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome. Dig. Dis. Sci. (1984) 29:614-619.
12. NORGARD B, FONAGER K, SORENSEN HT et al.: Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut (2003) 52:243-247.
13. MOGADAM M, DOBBINS WO III, AHMED SW et al.: Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology (1981) 80:72-76.
14. KORELITZ BI: Pregnancy, fertility; and inflammatory bowel disease. Am. J. Gastroenterol. (1985) 80:365-370.
15. KANE S: Inflammatory bowel disease in pregnancy. Gastroenterol. Clin. North Am. (2003) 32:323-340.
16. LOFTUS EV Jr, KANE SV, BJORKMAN D: Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment. Pharmacol. Ther. (2004) 19:179-189.
17. HENSLEIGH PA, KAUFFMAN RE: Maternal absorption and placental transfer of sulfasalazine. Am. J. Obstet. Gynecol. (1977) 127:443-444.
18. BELL CM, HABAL FM: Safety of topical 5-aminosalicylic acid in pregnancy. Am. J. Gastroenterol. (1997) 92:2201-2202.
19. DIAV-CITRIN O, PARK YH, VEERASUNTHARAM G et al.: The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology (1998) 114:23-28.
20. HABAL FM, HUI G, GREENBERG GR: Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology (1993) 105:1057-1060.
21. MARTEAU P, TENNENBAUM R, COSNES J et al.: Fetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment. Pharmacol. Ther. (1998) 12:1101-1108.
22. FERRERO S, RAGNI N: Inflammatory bowel disease: management issues during pregnancy. Arch. Gynecol. Obstet. (2004) 270:79-85.
23. ALSTEAD EM, NELSON-PIERCY C: Inflammatory bowel disease in pregnancy. Gut (2003) 52:159-161.
24. MOSKOVITZ DN, BODIAN C, CHAPMAN ML et al.: The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am. J. Gastroenterol. (2004) 99:656-661.
25. COLOMBEL JF, BRABANT G, GUBLER MC et al.: Renal insufficiency in infant: side effect of prenatal exposure to mesalazine? Lancet (1994) 344:620-621.
26. HERNANDEZ-DIAZ S, WERLER MM, MITCHELL AA et al.: Folic acid antagonists during pregnancy and the risk of birth defects. N. Engl. J. Med. (2000) 343:1608-1614.
27. WARRELL DW, TAYLOR R: Outcome for the fetus of mothers receiving prednisolone during pregnancy. Lancet (1968) 1:117-118.
28. BEITINS IZ, BAYARD F, MIGEON CJ et al.: The transplacental passage of prednisone and prednisolone in pregnancy near term. J. Pediatr. (1972) 81:936-945.
29. ROSENKRANTZ JG, GITHENS JH, KELLUM DL et al.: Azathioprine (Imuran) and pregnancy. Am. J. Obstet. Gynecol. (1967) 97:387-394.
30. SAARIKOSKI S, SEPPALA M: Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am. J. Obstet. Gynecol. (1973) 115:1100-1106.
31. DUBINSKY MC: Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol. Hepatol. (2004) 2:731-743.
32. MATALON ST, ORNOY A, LISHNER M: Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs. (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Reprod. Toxicol. (2004) 18:219-230.
33. PRESENT DH, MELTZER SJ, KORELITZ BI et al.: 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann. Intern. Med. (1989) 111:641-649.
34. PENN I, MAKOWSKI E, STARZL TE et al.: Parenthood in renal homograft recipients. JAMA (1971) 216:1755-1761.
35. GILLIBRAND PN: Systemic lupus erythematosus in pregnancy treated with azathioprine. Proc. R. Soc. Med. (1966) 59:834.
36. NORGARD B, PEDERSEN L, SORENSEN HT et al.: Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment. Pharmacol. Ther. (2003) 17:827-834.
37. FRANCELLA A, DYAN A, PRESENT DH et al.: The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology (2003) 124:9-17.
38. RAMSEY-GOLDMAN R, SCHILLING E: Immunosuppressive drug use during pregnancy. Rheum. Dis. Clin. North Am. (1997) 23:149-167.
39. BERTSCHINGER P, HIMMELMANN A, FOLLATH F et al.: Cyclosporin treatment of severe ulcerative colitis during pregnancy. Am. J. Gastroenterol. (1995) 90:330.
40. KORNBLUTH A, REDDY D: Management and outcome of severe colitis in pregnancy. Am. J. Gastroenterol. (2002) 97:P705.
41. GOLDENBERG M, BIDER D, OELSNER G et al.: Methotrexate therapy of tubal pregnancy. Hum. Reprod. (1993) 8:660-666.
42. KATZ JA, ANTONI C, LICHTENSTEIN GR et al.: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol. (2004) 99:2385-2392.
43. BURTIN P, TADDIO A, KOREN G et al.: Safety of metronidazole in pregnancy: a meta-analysis. Am. J. Obstet. Gynecol. (1995) 172:525-529.
44. DIAV-CITRIN O, SHECHTMAN S, ORNOY A et al.: Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology (2001) 63:186-192.
45. PIPER JM, MITCHEL EF, RAY WA: Prenatal use of metronidazole and birth defects: no association. Obstet. Gynecol. (1993) 82:348-352.
46. CARO-PATON T, CARVAJAL A, RODRIGUEZ-PINELLA E et al.: Is metronidazole teratogenic? A meta-analysis. Br. J. Clin. Pharmacol. (1997) 44:179-182.
47. LOEBSTEIN R, ADDIS A, HO E et al.: Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob. Agents Chemother. (1998) 42:1336-1339.
48. SCHAEFER C, AMOURA-ELEFANT E, VIAL T et al.: Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur. J. Obstet. Gynecol. Reprod. Biol. (1996) 69:83-89.
49. EINARSON A, MASTROIACOVO P, ARNON J et al.: Prospective, controlled, multi-centre study of loperamide in pregnancy. Can. J. Gastroenterol. (2000) 3:185-187.
50. GATTUSO JM, KAMM MA: Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf. (1994) 1:47-65.
51. KANE S, LEMIEUX N: The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am. J. Gastroenterol. (2005) 100:102-105.
52. NELIS GF: Diarrhoea due to 5-aminosalicyclic acid in breast milk. Lancet (1989) 1(8634):383.
53. KLOTZ U, HARINGS-KAIM A: Negligible excretion of 5-aminosalicylic acid in breast milk. Lancet (1993) 342:618-619.
54. NYBERG G, HALJAMAE U, KJEMELLER I et al.: Breastfeeding during treatment with cyclosporin. Transplantation (1998) 65:253-255.
55. MUNOZ-FLORES-THIAGARAJAN KD, EASTERLING T, BOND EF et al.: Breastfeeding by a cyclosporin-treated mother. Obstet. Gynecol. (2001) 97:816-818.
56. OST L, WETTRELL G, RANE A et al.: Prednisolone excretion in human milk. J. Pediatr. (1985) 106:1008-1011.
57. KANE S: Breastfeeding and IBD: safety and management issues. Inflammatory Bowel Disease Monitor. (2004) 6:50-52.